$LFST

LifeStance Health: Q2 Earnings Snapshot

LifeStance Health Group Inc. (LFST) reported Q2 net income of $23.6 million, or 6 cents per share, topping Wall Street expectations. Revenue was $435.4 million versus an expected $414.3 million, according to Zacks Investment Research. For the quarter ending September, the company forecast revenue of $420 million to $440 million, and full-year revenue of $1.69 billion to $1.73 billion.

Original reporting
Published Aug 6, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 2:49 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$LFST
Bullish
medium confidence
Mentioned
$LFST
Relevance
8/10
alphai data visualization · based on yumasun.com
Decision brief

The 30-second read

$LFSTBullishMed
01

Why it matters

The actionable elements are the Q2 beat versus analyst estimates and the company’s stated revenue ranges for the current quarter and full year, which can drive revisions to expectations and near-term positioning.

02

Market read

Company-specific earnings and guidance ranges create a fresh basis for traders to reprice LFST’s near-term revenue outlook.

03

What to watch

Traders may focus on segment growth, payer mix, and utilization trends, none of which are included in the provided text.

Relevance 8/10Novelty 7/10Timing: reported Q2 results and issued Q3 and full-year revenue guidance today

Background

LifeStance Health Group Inc. is an outpatient mental health services provider; this is an AP earnings snapshot with consensus comparisons and forward revenue guidance.

Company-level read

Ticker impact

$LFSTBullishMedium confidence
Context

LifeStance Health reported Q2 net income of $23.6 million, EPS of $0.06, and revenue of $435.4 million, topping expectations.

Expected impact

Bias modestly positive for the next session, with follow-through dependent on how the $420 million to $440 million Q3 revenue range compares to consensus.

Evidence & confidence

The article provides a concrete Q2 beat and specific Q3 and full-year revenue guidance ranges, which are actionable for positioning around the earnings release.

Market effects

Reinforces that outpatient mental health providers can deliver above-consensus revenue, supporting the group’s earnings-quality narrative.

Limited, as the disclosure is company-specific with no broader regional macro linkage.

Low, since the story is US-focused and not tied to global policy or cross-border demand shocks.

Counterpoint

A beat can still disappoint if margins or operating metrics deteriorate, but this article only discloses net income and revenue.

Key entities

  • LifeStance Health Group Inc.

    Reported Q2 net income of $23.6 million, EPS of $0.06, revenue of $435.4 million, and provided Q3 and full-year revenue guidance ranges.

  • Zacks Investment Research

    Provided the consensus EPS and revenue expectations cited in the article.

Related articles

$LFSTMedAI 8/10

LifeStance Health Group, Inc. Q2 2026 Earnings Call Summary

LifeStance Health Group reported Q2 2026 revenue growth of 26%, driven by higher visit volumes and a 6% rise in revenue per visit, and said visits per clinician rose 7% YoY. The company raised full-year 2026 guidance to $1.685B-$1.725B revenue and 13.2% adjusted EBITDA margins, approved a new $100M buyback, and reported Q2 free cash flow of $88M.

$LFSTHighAI 9/10

LifeStance (LFST) Q2 2026 Earnings Call Transcript

LifeStance (LFST) reported Q2 2026 results on an earnings call. Revenue rose to $435 million (+26%) on 2.6 million visits (+19%) and total revenue per visit of $167 (+6%). Adjusted EBITDA was $66 million (+94%) with a 15.2% margin. Full-year 2026 revenue guidance was raised to $1.685-$1.725 billion and adjusted EBITDA to $215-$235 million.

$LFSTHigh

LifeStance Health Group, Inc. (LFST): Results of Operations and Financial Condition

LifeStance Health Group, Inc. (LFST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 lfst-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Investor Relations Contact Monica Prokocki VP of Finance & Investor Relations 602-767-2100 investor.relations@lifestance.com LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook Announc

$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

$GRDNMed

Guardian Pharmacy Services Q2 Earnings Call Highlights

Guardian Pharmacy Services (GRDN) reported Q2 net income of $22.1M vs $8.8M a year earlier, including an $8.5M payer-dispute settlement recorded as other income. The company expects H2 revenue to fall low-single digits YoY due to IRA pricing reductions, with adjusted EBITDA margin stable in Q3 and seasonally higher in Q4. It also appointed Morris as COO and named a new CFO.